Sonim Technologies reports FY2024: Q4 revenue $15M (+12%), full year $58.3M (-38%)

DNA X, Inc.

2025-Q1 EPS reported $0.08 revenue$16,721,000

Q4 revenue $15.0M (+12% YoY); full year revenue $58.3M (-38% YoY) due to strategic shift from white-label to own products.
Q4 gross margin negative 1%; full year 17%; $3.0M impairment on contract fulfillment assets reduced gross margin by 20pp in Q4.
Cash $5.3M at year-end; post-year-end raised $3.7M from ATM and $3.0M from new debt.
New product launches include H500 5G hotspot, XP Pro ultra rugged smartphone; secured carrier agreements with Verizon, Telstra, etc.
2025 outlook optimistic for revenue growth and profitability as new products scale globally.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.